GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eisai Co Ltd (FRA:EIIA) » Definitions » Shiller PE Ratio

Eisai Co (FRA:EIIA) Shiller PE Ratio : (As of May. 15, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Eisai Co Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Eisai Co Shiller PE Ratio Historical Data

The historical data trend for Eisai Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eisai Co Shiller PE Ratio Chart

Eisai Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.69 9.59 7.21 9.70 -

Eisai Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.70 12.67 11.09 9.29 -

Competitive Comparison of Eisai Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Eisai Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eisai Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eisai Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Eisai Co's Shiller PE Ratio falls into.



Eisai Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Eisai Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Eisai Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.071/107.2000*107.2000
=0.071

Current CPI (Mar. 2024) = 107.2000.

Eisai Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.143 98.000 0.156
201409 0.120 98.500 0.131
201412 0.625 97.900 0.684
201503 0.176 97.900 0.193
201506 0.137 98.400 0.149
201509 0.145 98.500 0.158
201512 0.719 98.100 0.786
201603 0.461 97.900 0.505
201606 0.582 98.100 0.636
201609 0.250 98.000 0.273
201612 0.300 98.400 0.327
201703 0.027 98.100 0.030
201706 0.275 98.500 0.299
201709 0.238 98.800 0.258
201712 0.243 99.400 0.262
201803 0.634 99.200 0.685
201806 0.334 99.200 0.361
201809 0.543 99.900 0.583
201812 0.200 99.700 0.215
201903 0.650 99.700 0.699
201906 0.619 99.800 0.665
201909 0.157 100.100 0.168
201912 1.331 100.500 1.420
202003 1.423 100.300 1.521
202006 0.703 99.900 0.754
202009 0.038 99.900 0.041
202012 0.535 99.300 0.578
202103 -0.087 99.900 -0.093
202106 1.107 99.500 1.193
202109 0.106 100.100 0.114
202112 0.384 100.100 0.411
202203 -0.082 101.100 -0.087
202206 0.166 101.800 0.175
202209 0.022 103.100 0.023
202212 0.053 104.100 0.055
202303 0.099 104.400 0.102
202306 0.116 105.200 0.118
202309 0.031 106.200 0.031
202312 0.033 106.800 0.033
202403 0.071 107.200 0.071

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Eisai Co  (FRA:EIIA) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Eisai Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Eisai Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Eisai Co (FRA:EIIA) Business Description

Traded in Other Exchanges
Address
4-6-10 Koishikawa, Bunkyo-ku, Tokyo, JPN, 112-8088
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of a pharmaceutical business and other businesses. The pharmaceutical business is categorized by region, including Japan, Americas, China, Asia, and Europe, Middle East, and Africa. Eisai also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived by its Japanese pharmaceutical business, followed by its Americas pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.

Eisai Co (FRA:EIIA) Headlines

No Headlines